KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

Kazia Key Milestones and Newsflow

  1. Rich&Poor
    1,206 Posts.
    lightbulb Created with Sketch. 941
    clock Created with Sketch.
    08/11/20
    22:36
    Post #: 48724017
    Very impressive 2020 AGM Chairman's address and CEO presentation last Friday.

    Kazia's anticipated Key Milestones and Newsflow schedule over the next 7.5 months is incredible for a company of our size.

    In particular looking forward to the interim data from both :-
    Initial interim data from phase II BCBM trial at Dana-Farber - Q4 CY2020
    Initial interim data from phase II brain mets study by Alliance Group - H1 CY2021

    IMO any favorable paxalisib published data from either study, will finally see Genentech extremely interested in PAXALISIB and participate in discussions at the negotiation table.

    Regards.

    https://hotcopper.com.au/data/attachments/2631/2631269-23027925b67b0e3510fc7e8416209347.jpg


    KZA Price at posting: 82.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 14  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.